751361
Last Update Posted: 2008-09-11
Recruiting has ended
All Genders accepted | 50 Years-85 Years |
52 Estimated Participants | No Expanded Access |
Interventional Study | Does not accept healthy volunteers |
Dry Age-Related Macular Degeneration (AMD) Treatment With Rheopheresis Trial
Purpose is to evaluate Rheopheresis for the treatment of patients with high-risk dry age-related macular degeneration and no therapeutic alternative. Rheopheresis is a method of therapeutic apheresis using the methodology of double filtration plasmapheresis to treat microcirculatory disorders.
Eligibility
Relevant conditions:
Dry Age Related Macular Degeneration
If you aren't sure if you meet the criteria above speak to your healthcare professional. Criteria may be updated but not reflected here, do not hesitate to contact the study if you think are close to fitting criteria.
locations
Data sourced from ClinicalTrials.gov